TBPH

NASDAQStock

Theravance Biopharma, Inc.

$13.64-0.24 (-1.76%)

52-Week Range

$8.32
$20.74

Key Stats

Market Cap

691.4M

P/E Ratio

Dividend Yield

Beta

0.11

Volume

378.4K

Avg Volume

1.1M

Performance

1M

-28.40%

3M

-21.83%

6M

-3.54%

YTD

-23.47%

1Y

+50.49%

3Y

+31.53%

5Y

-32.57%

Price Chart

ETF Exposure

TBPH is held by 102 ETFs

ETFFund NameWeight
VIRSPacer BioThreat Strategy ETF0.02%
XRS2.DEXtrackers Russell 2000 UCITS ETF 1C0.02%
XRSU.LXtrackers Russell 2000 UCITS ETF 1C0.02%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF0.01%
SCHASchwab U.S. Small-Cap ETF0.01%
UWMProShares - Ultra Russell20000.01%
URTYProShares - UltraPro Russell20000.01%
VHTVanguard Health Care ETF0.01%
FESMFIDELITY ENHANCED SMALL CAP ETF0.01%
ISCBiShares Morningstar Small-Cap ETF0.01%
JKJiShares Morningstar Small-Cap ETF0.01%
VTWVVanguard Russell 2000 Value ETF0.01%
VXFVanguard Extended Market ETF0.01%
FHLCFIDELITY MSCI HEALTH CARE INDEX ETF0.01%
IWNiShares Russell 2000 Value ETF0.01%
CUS1.LiShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF0.01%
CUSS.LiShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF0.01%
SXRG.DEiShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF0.01%
IUSN.DEiShares MSCI World Small Cap UCITS ETF0.01%
WSML.LiShares MSCI World Small Cap UCITS ETF0.01%
AVSUAvantis Responsible U.S. Equity ETF0.01%
WSMLiShares MSCI World Small-Cap ETF0.01%
DFACDimensional - US Core Equity 2 ETF0.00%
SMMDiShares Russell 2500 ETF0.00%
HDGProShares - Hedge Replication ETF0.00%
AVUSAvantis U.S. Equity ETF0.00%
DCORDimensional - US Core Equity 1 ETF0.00%
DFAUDimensional - US Core Equity Market ETF0.00%
DFUSDimensional - US Equity Market ETF0.00%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
IWViShares Russell 3000 ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
USFM.LUBS MSCI USA Select Factor Mix UCITS ETF USD dis0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%
DXUVDimensional - US Vector Equity ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
PreviousPage 2 of 3Next

About TBPH ETF Exposure

Theravance Biopharma, Inc. (TBPH) is held by 102 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 691.4M, TBPH is a widely held institutional stock. The stock currently trades at $13.64. Investors can gain exposure to TBPH through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TBPH, sorted by portfolio weight.